See All Slides - tctmd.com

Slides

Presentation TCT 2012

CTSN Trials: Rationale and Status

Presenter: Michael Argenziano

October 23, 2012

Presentation TCT 2012

Tips and Tricks for Successful Crossing of Femoropopliteal CTOs

Presenter: Andrej Schmidt

October 23, 2012

Presentation TCT 2012

Introduction(10)

Presenter: Dennis McNamara

October 23, 2012

Presentation TCT 2012

Leveraging IT Systems to Improve Operational Performance

Presenter: Andrew Proctor

October 23, 2012

Presentation TCT 2012

Balancing Device Polymeric Load and Long-term Absorption Will Result in the Ideal DES Platform: Bioresorbable Vascular Scaffolds Are the Future!

Presenter: Jean-Fran?ois Tanguay

October 23, 2012

Presentation TCT 2012

Pro: Ticagrelor!

Presenter: David Kong

October 23, 2012

Presentation TCT 2012

TCT-55. Major Adverse Cardiac Events Associated with Discontinuation of Clopidogrel Treatment Within the First Year After Coronary Stent Implantation in Western Denmark

Presenter: Michael Maeng

October 23, 2012

Presentation TCT 2012

Perspective 2

Presenter: Christopher Nelson

October 23, 2012

Presentation TCT 2012

Vasomotion After Metallic and Bioabsorbable Implants: Evaluation and Clinical Relevance

Presenter: Ian Meredith

October 23, 2012

Presentation TCT 2012

Do Beta Blockade, Afterload Reduction, and Other Medical Therapies Improve Prognosis in Functional MR? Review of the Literature and Practical Recommendations

Presenter: Jason Rogers

October 23, 2012

Advertisement

Slides

CTSN Trials: Rationale and Status

Tips and Tricks for Successful Crossing of Femoropopliteal CTOs

Introduction(10)

Leveraging IT Systems to Improve Operational Performance

Balancing Device Polymeric Load and Long-term Absorption Will Result in the Ideal DES Platform: Bioresorbable Vascular Scaffolds Are the Future!

Pro: Ticagrelor!

TCT-55. Major Adverse Cardiac Events Associated with Discontinuation of Clopidogrel Treatment Within the First Year After Coronary Stent Implantation in Western Denmark

Perspective 2

Vasomotion After Metallic and Bioabsorbable Implants: Evaluation and Clinical Relevance

Do Beta Blockade, Afterload Reduction, and Other Medical Therapies Improve Prognosis in Functional MR? Review of the Literature and Practical Recommendations

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content